Qualigen Therapeutics, Inc. financial data

Symbol
QLGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
2042 Corte Del Nogal, Carlsbad, California, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
RITTER PHARMACEUTICALS INC (to 5/20/2020)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 28 % -67.1%
Quick Ratio 20.2 % -21%
Debt-to-equity 938 % +1361%
Return On Equity 261 %
Return On Assets -534 % -304%
Operating Margin -196 % +49.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 736K shares -85.8%
Common Stock, Shares, Outstanding 548K shares -89.1%
Entity Public Float 4.57M USD -79.2%
Common Stock, Value, Issued 65.3K USD +52.1%
Weighted Average Number of Shares Outstanding, Basic 7.6M shares +50.5%
Weighted Average Number of Shares Outstanding, Diluted 388K shares +284%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.07M USD +26.7%
Research and Development Expense 2.55M USD -37.5%
General and Administrative Expense 4.15M USD -43.2%
Operating Income (Loss) -6.71M USD +40%
Nonoperating Income (Expense) -1.08M USD +4.89%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.78M USD +36.8%
Income Tax Expense (Benefit) -2.2K USD
Net Income (Loss) Attributable to Parent -7.85M USD +54.7%
Earnings Per Share, Basic -0.21 USD/shares +69.6%
Earnings Per Share, Diluted -4.7 USD/shares +87%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 388K USD
Accounts Receivable, after Allowance for Credit Loss, Current 539K USD 0%
Inventory, Net 1.56M USD +19.3%
Other Assets, Current 11.6K USD
Assets, Current 2.31M USD -32.9%
Property, Plant and Equipment, Net 499K USD +51.3%
Operating Lease, Right-of-Use Asset 1.31M USD -15%
Intangible Assets, Net (Excluding Goodwill) 5.83M USD -0.43%
Goodwill 626K USD -87.2%
Other Assets, Noncurrent 866K USD +4626%
Assets 2.31M USD -46.4%
Accounts Payable, Current 1.64M USD +4.24%
Accrued Liabilities, Current 570K USD -50.2%
Liabilities, Current 4.45M USD -25.2%
Deferred Income Tax Liabilities, Net 150K USD
Operating Lease, Liability, Noncurrent 1.17M USD -18%
Liabilities 4.14M USD -59.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 132K USD +101%
Retained Earnings (Accumulated Deficit) -122M USD -6.87%
Stockholders' Equity Attributable to Parent -2.1M USD -129%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2.14M USD -30.5%
Liabilities and Equity 2.31M USD -46.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -784K USD +70.3%
Net Cash Provided by (Used in) Financing Activities 475K USD
Net Cash Provided by (Used in) Investing Activities -198K USD -299%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 548K shares -89.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -800K USD +69.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 388K USD -81.3%
Deferred Tax Assets, Valuation Allowance 17.8M USD -61%
Deferred Tax Assets, Gross 17.8M USD -61%
Operating Lease, Liability 1.43M USD -11.1%
Depreciation 84K USD -4.55%
Payments to Acquire Property, Plant, and Equipment 198K USD +299%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.84M USD +54.9%
Lessee, Operating Lease, Liability, to be Paid 1.74M USD -21%
Property, Plant and Equipment, Gross 5.25M USD +40.3%
Operating Lease, Liability, Current 257K USD +44.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 391K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 379K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 310K USD -47.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 402K USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 8.64M USD -73.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 379K USD -5.8%
Additional Paid in Capital 120M USD +6.51%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5K USD +66.7%
Depreciation, Depletion and Amortization 58.7K USD +97.2%
Share-based Payment Arrangement, Expense 755K USD -77.1%
Interest Expense 28K USD -92.4%